Bifogade filer
Optomed Q2 - Soft Q2 sales raises the stakes for H2 recovery
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2025-08-08 15:30:00
Redeye provides an update following Optomed’s Q2 2025 report. Sales came in below our expectations, and we had anticipated a more pronounced impact from the Aurora AEYE camera. As a result, we have made downward adjustments to our sales estimates, leading to an updated fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/